Boothbay Fund Management’s Celldex Therapeutics CLDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.06M	Buy	+33,300	New	+$908K	0.02%	919
2025 Q1	–	Sell	-60,900	Closed	-$1.54M	–	1467
2024 Q4	$1.54M	Sell	60,900 -29,300	-32%	-$796K	0.05%	514
2024 Q3	$3.07M	Buy	+90,200	New	+$3.44M	0.09%	388
2023 Q4	–	Sell	-19,800	Closed	-$545K	–	1705
2023 Q3	$545K	Buy	+19,800	New	+$621K	0.02%	996
2023 Q2	–	Sell	-22,500	Closed	-$810K	–	1895
2023 Q1	$810K	Buy	+22,500	New	+$971K	0.02%	1083
2022 Q3	–	Sell	-87,500	Closed	-$2.36M	–	2286
2022 Q2	$2.36M	Buy	87,500 +21,800	+33%	+$633K	0.07%	483
2022 Q1	$2.24M	Buy	65,700 +18,700	+40%	+$598K	0.07%	535
2021 Q4	$1.82M	Sell	47,000 -5,200	-10%	-$227K	0.06%	511
2021 Q3	$2.82M	Buy	+52,200	New	+$2.45M	0.11%	325
2018 Q2	–	Sell	-76	Closed	-$264K	–	771
2018 Q1	$264K	Buy	+76	New	+$2.94K	0.04%	522